Ask the MPN Expert - LIVE

August 28, 2018



  Register Now

Do you have a burning question for an expert in myeloproliferative neoplasms (MPNs)? On Tuesday, August 28 at 5:00pm Eastern time (4:00pm Central, 2:00pm Pacific), Patient Power will host a LIVE, 30-minute “Ask the Expert” session with MPN specialist Dr. Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center.

Don’t miss this opportunity to voice questions about your condition and hear directly from an expert. Send in your questions to mpn@patientpower.info, and we’ll do our best to get it answered during the live program.

You must register in advance to receive a link to the program and instructions for attending. 

Please note that we try to respond to all appropriate questions, but cannot provide specific medical advice over the Internet. We always recommend that you seek care from your own doctor, or an MPN specialist, that’s how you’ll get the best treatment for you.


  Register Now
Host & Guests
Host

Host, Patient Power Co-Founder, Two-Time Cancer Survivor and MPN Patient Advocate


Guests

Register Now

I understand that the information I've provided will only be accessed by Patient Power, LLC and its contracted third parties to mail (and email) helpful information about cancer and related products and services. Patient Power will not sell or transfer my name or contact information to any third party for their marketing use.


Log in    Already a member? Log in now.

Community Member Account





Help us to better understand you


Stay Informed


Can't read the security code? Refresh Code

If you are having issues with the registration form, please call (206) 232-1542 to register over the phone or email questions@patientpower.info.


Ask the Expert “Live” | MPNs is a Patient Empowerment Network program produced by Patient Power. We thank Incyte Corporation for their support.

Patient Power
Patient Empowerment Network
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 7, 2018